Stay updated on Tirzepatide in OSA: Clinical Trial
Sign up to get notified when there's something new on the Tirzepatide in OSA: Clinical Trial page.

Latest updates to the Tirzepatide in OSA: Clinical Trial page
- Check2 days agoChange DetectedThe footer revision identifier changed from v3.7.1 to v3.7.2 while the study record page remained inaccessible with a 403 error.SummaryDifference0.2%

- Check9 days agoChange DetectedThe ClinicalTrials.gov footer revision identifier changed from v3.7.0 to v3.7.1, while the study page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check16 days agoChange DetectedThe study record page now shows a 403 Forbidden message and a Home link rather than clinical trial information.SummaryDifference0.5%

- Check30 days agoChange DetectedThe study page now displays a 403 Forbidden error page, replacing the detailed study content and navigation. This indicates restricted access to the NCT05412004 record on ClinicalTrials.gov.SummaryDifference19%

- Check44 days agoChange DetectedA new publication citation by Falcon et al. was added to the Publications section, reflecting post hoc analyses related to SURMOUNT-OSA. Several MeSH/related topics entries—'Obstructive sleep apnea', 'related topics:', and 'MedlinePlus Genetics'—were removed from the MeSH terms area, altering the indexing and related topics presentation.SummaryDifference0.1%

- Check51 days agoChange DetectedThe page now shows Revision: v3.6.6, replacing the previous v3.6.5. This reflects a minor maintenance update to the page's revision tracking.SummaryDifference0.0%

Stay in the know with updates to Tirzepatide in OSA: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tirzepatide in OSA: Clinical Trial page.